Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain

C Chaves, F Remiao, S Cisternino… - Current …, 2017 - ingentaconnect.com
Background: Opioids are widely used in pain management, acting via opioid receptors
and/or Toll-like receptors (TLR) present at the central nervous system (CNS). At the blood …

Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain

CM Peters, JR Ghilardi, CP Keyser, K Kubota… - Experimental …, 2005 - Elsevier
Bone is the most common site of chronic pain in patients with metastatic cancer. What
remains unclear are the mechanisms that generate this pain and why bone cancer pain can …

Cancer pain and analgesia

PJ Christo, D Mazloomdoost - … of the New York Academy of …, 2008 - Wiley Online Library
Pain ranges in prevalence from 14–100% among cancer patients and occurs in 50–70% of
those in active treatment. Cancer pain may result from direct invasion of tumor into nerves …

Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study

E Bruera, JL Palmer, S Bosnjak, MA Rico… - Journal of Clinical …, 2004 - ascopubs.org
Purpose To compare the effectiveness and side effects of methadone and morphine as first-
line treatment with opioids for cancer pain. Patients and Methods Patients in international …

A review of morphine and morphine-6-glucuronide's pharmacokinetic–pharmacodynamic relationships in experimental and clinical pain

E Sverrisdóttir, TM Lund, AE Olesen, AM Drewes… - European Journal of …, 2015 - Elsevier
Morphine is a widely used opioid for treatment of moderate to severe pain, but large
interindividual variability in patient response and no clear guidance on how to optimise …

Efficacy and ligand bias at the μ‐opioid receptor

E Kelly - British journal of pharmacology, 2013 - Wiley Online Library
In order to describe drug action at a GPCR, a full understanding of the pharmacological
terms affinity, efficacy and potency is necessary. This is true whether comparing the ability of …

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover …

S Mercadante, L Radbruch, A Davies… - … medical research and …, 2009 - Taylor & Francis
Objective: The efficacy of intranasal fentanyl spray (INFS) was compared with that of oral
transmucosal fentanyl citrate (OTFC) for the relief of cancer-related breakthrough pain (BTP) …

Adult cancer pain

R Swarm, AP Abernethy, DL Anghelescu… - Journal of the National …, 2010 - jnccn.org
Overview Pain, defined as “a sensory and emotional experience associated with actual or
potential tissue damage or described in terms of such damage,” 1 is one of the most …

Management of cancer pain: ESMO clinical practice guidelines

CI Ripamonti, E Bandieri, F Roila - Annals of oncology, 2011 - annalsofoncology.org
According to the World Health Organization (WHO), the incidence of cancer was 12 667 470
new cases in 2008 and, based on projections, it will be> 15 million in 2020 [1]. Consistent …

Pathogenesis and treatment of pancreatic cancer related pain

I Lohse, SP Brothers - Anticancer research, 2020 - ar.iiarjournals.org
Pancreatic cancer is often diagnosed due to the patient seeking medical attention for
abdominal pain. It is among the most painful cancers, with pain severity strongly correlating …